Filter
946
Text search:
ncov
Featured
199
3
Language
Document type
529
117
108
69
37
23
15
12
10
9
9
7
1
Countries / Regions
81
59
48
41
35
32
31
31
29
28
27
27
24
22
19
17
16
13
12
9
9
9
9
8
8
8
7
7
7
7
6
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
425
20
18
17
16
11
7
Toolboxes
850
16
16
12
10
6
6
5
4
4
3
2
2
2
2
1
1
1
1
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
Update on SARS-CoV-2 variant of concern Omicron
recommended
Update 70, 10 Dec. 2021
The World Health Organization (WHO) has identified mental health as an integral component of the COVID-19 response. Its rapid assessment of service delivery for mental, neurological and substance use (MNS) disorders during the COVID-19 pandemic, on which this report is based, is the first attempt to
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Consensual Recommendation for treatment of COVID-19 in older adults
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
Vaccination against COVID-19 in Indigenous peoples and nationalities,
Afro-Ecuadorian and Montubio peoples and nationalities of Ecuador
Operational Guidelines
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
From the start of the COVID-19 pandemic until August 2021, extreme weather events have affected at least 139.2 million people and killed at least 17,242 people in at least 433 unique events. These figures are certainly an underestimate, as they do not include estimates of numbers of people affected
...
Active Community Policy Strategy - Containment, mitigation and recovery plan on post-confinement in response to COVID-19
Updated Treatment Guidelines
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir
...
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag
...
Consolidated recommendations for palliative care in the SARS pandemic-Cov-2/COVID-19 2020
COVID-19, General Epidemiological Surveillance Guidelines (Version 6)
